Oct. 24 at 6:46 PM
$ALDX Eylocity is a great name for a new drug, and nobody’s going to forget it easily! It won’t take much to make Eylocity a household name because millions of patients with Dry Eye are waiting for it, and some go without any treatment because of lack of effective remedies.
It’s been a decade and a half since there’s been a new treatment, and patients are clamoring for something that works. Buy more shares now, because approval is less than two months away, and ALDX has already met the clinical endpoints required by the FDA in its CRL! Extremely bullish!
